Also on Trial Friend:Eosinophilic Granulomatosis with Polyangiitis pageMatch Me
All 13 Eosinophilic Granulomatosis with Polyangiitis trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentMost sites in Colorado, Maryland and MichiganRecruitingPhase 3Ages 6+AstraZeneca8US sites
8 states - A Trial to Investigate Benralizumab in Children With Eosinophilic DiseasesMost sites in Ohio and ColoradoRecruitingPhase 3Ages 6-17AstraZeneca3US sites
2 states - Clinical Transcriptomics in Systemic Vasculitis (CUTIS)Most sites in Pennsylvania and VirginiaRecruitingAges 5+Peter Merkel2US sites
2 states - One-Time DNA Study for VasculitisMost sites in Illinois and PennsylvaniaRecruitingAges 7+University of Pennsylvania2US sites
2 states - Vasculitis Pregnancy RegistryOnly in FloridaRecruitingAges 18-50University of Pennsylvania1US site
- VCRC Tissue RepositoryOnly in PennsylvaniaRecruitingUniversity of Pennsylvania1US site
- A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）RecruitingPhase 2/3Ages 18+Guangdong Hengrui Pharmaceutical Co.No US site yet
- Benralizumab Effectiveness in EGPARecruitingAges 18+European EGPA Study GroupNo US site yet
- eGPA and Local Inflammation Within the Ear, Nose and Throat AreaRecruitingAges 18+University Medical Center GroningenNo US site yet
- Longitudinal Study for Eosinophilic Granulomatosis With PolyangiitisRecruitingUniversity of PennsylvaniaNo US site yet
- Ocular Manifestations of Granulomatosis With Polyangiitis.RecruitingAges 18+Military Institute od Medicine National Research InstituteNo US site yet
- Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing EosinophilsRecruitingAges 18+Medical University InnsbruckNo US site yet
- The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic SyndromeRecruitingAges 18+Fondazione IRCCS Policlinico San Matteo di PaviaNo US site yet
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Eosinophilic Granulomatosis with Polyangiitis trials in the US, and what stage they are in
Of the 6 Eosinophilic Granulomatosis with Polyangiitis trials with a US site, 2 are in Phase 3, the last stage before a company can ask the FDA for approval. The remaining 4 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 2 of them, and universities, hospitals, foundations and government groups run 4. The sponsors with the most are University of Pennsylvania (3) and AstraZeneca (2). The most recently listed one first appeared on ClinicalTrials.gov on March 3, 2026.
Eosinophilic Granulomatosis with Polyangiitis trials in the US, state by state
Of the 6 Eosinophilic Granulomatosis with Polyangiitis trials with a US site, 5 accept children under 18. Their open sites are in 11 states, most often Pennsylvania, Colorado and Ohio. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 2 states
US hospitals running the most Eosinophilic Granulomatosis with Polyangiitis trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Eosinophilic Granulomatosis with Polyangiitis.
- University of PennsylvaniaPhiladelphia, Pennsylvania3 trials
- Northwestern UniversityChicago, Illinois1 trial
- University of South Florida Data Management and Coordinating CenterTampa, Florida1 trial
- University of VirginiaCharlottesville, Virginia1 trial
Help getting to an Eosinophilic Granulomatosis with Polyangiitis trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding an Eosinophilic Granulomatosis with Polyangiitis trial near you
Are there Eosinophilic Granulomatosis with Polyangiitis clinical trials near me?
As of November 13, 2026, 13 Eosinophilic Granulomatosis with Polyangiitis clinical trials are recruiting now and 1 is not yet recruiting. In the US, 6 of them have at least 1 open site, across 12 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Eosinophilic Granulomatosis with Polyangiitis clinical trial sites?
Recruiting Eosinophilic Granulomatosis with Polyangiitis trials list open sites in Colorado, Florida, Illinois, Maryland, Michigan, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Utah and Virginia.
Are there Eosinophilic Granulomatosis with Polyangiitis trials for children near me?
Of the 6 Eosinophilic Granulomatosis with Polyangiitis trials with a US site, 5 accept children under 18. Their open sites are in 11 states, most often Pennsylvania, Colorado and Ohio. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to an Eosinophilic Granulomatosis with Polyangiitis clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.
What if there is no Eosinophilic Granulomatosis with Polyangiitis trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when an Eosinophilic Granulomatosis with Polyangiitis trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Eosinophilic Granulomatosis with Polyangiitis: Fasenra (benralizumab), Nucala (mepolizumab).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.